Skip to the page

Data / Form D filings / Curavit Clinical Research Corp

Curavit Clinical Research Corp: Form D filings

Curavit Clinical Research Corp, a health care company in Scarsdale, NY, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on September 5, 2024, reports $11.4 million sold of a $11.6 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
18 LARCH LANE, Scarsdale, NY, 10583
Phone
(917) 885-0024
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1947723

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 5, 2024Amendment$11,646,575$11,426,701$219,87430Sep 28, 2022sec.gov
Mar 8, 2024Amendment$10,393,329$10,116,574$276,75530Sep 28, 2022sec.gov
Oct 13, 2022New notice$8,893,329$8,493,329$400,00026Sep 28, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jackie KentDirector
Rich LesterDirector
Joel MorseExecutive Officer, Director
Nathanael LentzDirector
David HanamanDirector

Other health care companies in New York that filed recently

Every Form D from the week of Sep 2, 2024 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Curavit Clinical Research Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.